Advanced search

Docosahexaenoic Acid Trials in Cystic Fibrosis: a Review of the Rationale behind the Clinical Trials

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Van Biervliet, Stephanie, J VAN BIERVLIET, Eddy Robberecht, and Armand Christophe. 2005. “Docosahexaenoic Acid Trials in Cystic Fibrosis: a Review of the Rationale Behind the Clinical Trials.” Journal of Cystic Fibrosis 4: 27–34.
APA
Van Biervliet, Stephanie, VAN BIERVLIET, J., Robberecht, E., & Christophe, A. (2005). Docosahexaenoic Acid Trials in Cystic Fibrosis: a Review of the Rationale behind the Clinical Trials. JOURNAL OF CYSTIC FIBROSIS, 4, 27–34.
Vancouver
1.
Van Biervliet S, VAN BIERVLIET J, Robberecht E, Christophe A. Docosahexaenoic Acid Trials in Cystic Fibrosis: a Review of the Rationale behind the Clinical Trials. JOURNAL OF CYSTIC FIBROSIS. 2005;4:27–34.
MLA
Van Biervliet, Stephanie, J VAN BIERVLIET, Eddy Robberecht, et al. “Docosahexaenoic Acid Trials in Cystic Fibrosis: a Review of the Rationale Behind the Clinical Trials.” JOURNAL OF CYSTIC FIBROSIS 4 (2005): 27–34. Print.
@article{336879,
  author       = {VAN BIERVLIET, STEPHANIE and VAN BIERVLIET, J and Robberecht, Eddy and Christophe, Armand},
  issn         = {1569-1993},
  journal      = {JOURNAL OF CYSTIC FIBROSIS},
  pages        = {27--34},
  title        = {Docosahexaenoic Acid Trials in Cystic Fibrosis: a Review of the Rationale behind the Clinical Trials},
  volume       = {4},
  year         = {2005},
}